The DOI matches its Crossref record; 224 of the 224 references it cites were found in a registry or an index.
Protein aggregation in amyotrophic lateral sclerosis
Open accessAbstract
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the aggregation of ubiquitinated proteins in affected motor neurons. Recent studies have identified several new molecular constituents of ALS-linked cellular aggregates, including FUS, TDP-43, OPTN, UBQLN2 and the translational product of intronic repeats in the gene C9ORF72. Mutations in the genes encoding these proteins are found in a subgroup of ALS patients and segregate with disease in familial cases, indicating a causal relationship with disease pathogenesis. Furthermore, these proteins are often detected in aggregates of non-mutation carriers and those observed in other neurodegenerative disorders, supporting a widespread role in neuronal degeneration. The molecular characteristics and distribution of different types of protein aggregates in ALS can be linked to specific genetic alterations and shows a remarkable overlap hinting at a convergence of underlying cellular processes and pathological effects. Thus far, self-aggregating properties of prion-like domains, altered RNA granule formation and dysfunction of the protein quality control system have been suggested to contribute to protein aggregation in ALS. The precise pathological effects of protein aggregation remain largely unknown, but experimental evidence hints at both gain- and loss-of-function mechanisms. Here, we discuss recent advances in our understanding of the molecular make-up, formation, and mechanism-of-action of protein aggregates in ALS. Further insight into protein aggregation will not only deepen our understanding of ALS pathogenesis but also may provide novel avenues for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–224 of 224
Tanji, K., Zhang, H., Mori, F., Kakita, A., Takahashi, H., & Wakabayashi, K. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23081 · Cited by 76
Chiò, A., Calvo, A., Moglia, C., Restagno, G., Ossola, I., Brunetti, M., Montuschi, A., Cistaro, A., Ticca, A., Traynor, B. J., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.173 · Cited by 74
Novel optineurin mutations in sporadic amyotrophic lateral sclerosis patients
van Blitterswijk, M., van Vught, P. W. J., van Es, M. A., Schelhaas, H. J., van der Kooi, A. J., de Visser, M., Veldink, J. H., & van den Berg, L. H. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.019 · Cited by 74
Gregory, J. M., de Barros, T. P., Meehan, S., Dobson, C. M., & Luheshi, L. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031899 · Cited by 71
Kryndushkin, D. S., Ihrke, G., Piermartiri, T., & Shewmaker, F. P. (2012) · Molecular Microbiology · doi:10.1111/mmi.12075 · Cited by 69
Braak, H., Ludolph, A. C., Thal, D. R., & Tredici, K. D. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0683-0 · Cited by 68
Deng, H.-X. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.178 · Cited by 67
Wojtas, A., Heggeli, K., Finch, N. A., Baker, M. C., DeJesus‐Hernandez, M., Younkin, S. G., Dickson, D. W., Graff‐Radford, N. R., & Rademakers, R. (2012) · Europe PMC (PubMed Central) · Cited by 67
Ito, H., Fujita, K., Nakamura, M., Wate, R., Kaneko, S., Sasaki, S., Yamane, K., Suzuki, N., Aoki, M., Shibata, N., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0809-z · Cited by 63
Gertz, B., Wong, M., & Martin, L. J. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318244b635 · Cited by 62
Ubiquilins in the crosstalk among proteolytic pathways
Lee, D. Y., & Brown, E. J. (2012) · Biological Chemistry · doi:10.1515/hsz-2012-0120 · Cited by 62
Accumulation of insoluble forms of FUS protein correlates with toxicity in Drosophila
Miguel, L., Avequin, T., Delarue, M., Feuillette, S., Frébourg, T., Campion, D., & Lecourtois, M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.008 · Cited by 62
Geser, F., Prvulovic, D., O’Dwyer, L., Hardiman, O. M., Bede, P., Bokde, A. L. W., Trojanowski, J. Q., & Hampel, H. J. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.011 · Cited by 62
Kariya, S., Ré, D. B., Jacquier, A., Nelson, K. N., Przedborski, S., & Monani, U. R. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds174 · Cited by 58
Borghero, G., Floris, G., Cannas, A., Marrosu, M. G., Murru, M. R., Costantino, E., Parish, L. D., Pugliatti, M., Ticca, A., Traynor, B. J., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.06.009 · Cited by 57
Nihei, Y., Ito, D., & Suzuki, N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.398099 · Cited by 54
Analysis of OPTN as a causative gene for amyotrophic lateral sclerosis
Belzil, V., Daoud, H., Desjarlais, A., Bouchard, J.-P., Dupré, N., Camu, W., Dion, P. A., & Rouleau, G. A. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.10.001 · Cited by 53
Novel deletion mutations of OPTN in amyotrophic lateral sclerosis in Japanese
Iida, A., Hosono, N., Sano, M., Kamei, T., Oshima, S., Tokuda, T., Nakajima, M., Kubo, M., Nakamura, Y., & Ikegawa, S. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.12.037 · Cited by 50
Mosca, L., Lunetta, C., Tarlarini, C., Avemaria, F., Maestri, E., Melazzini, M. G., Corbo, M., & Penco, S. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.01.108 · Cited by 48
Li, Z., Lu, Y., Xu, X., & Gao, F. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds420 · Cited by 46
Novel TARDBP mutations in Nordic ALS patients
Chiang, H., Andersen, P. M., Tysnes, O., Gredal, O., Christensen, P., & Graff, C. (2012) · Journal of Human Genetics · doi:10.1038/jhg.2012.24 · Cited by 36
Sun, Y., Yang, P., Zhang, Y., Bao, X., Li, J., Hou, W., Yao, X., Han, J., & Zhang, H. (2011) · Protein & Cell · doi:10.1007/s13238-011-1119-x · Cited by 33
Contribution of TARDBP to Alzheimer's Disease Genetic Etiology
Brouwers, N., Bettens, K., Gijselinck, I., Engelborghs, S., Pickut, B. A., Miegroet, H. V., Montoya, A. G., Mattheijssens, M., Peeters, K., Deyn, P. P. D., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100198 · Cited by 26
Hernández, I., Espinosa, A., Real, L. M., Galán, J. J., Mauleón, A., Rosende‐Roca, M., Tárraga, L., Ruiz, A., & Boada, M. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6568-5 · Cited by 3
Cited by
Sharifi-Rad, M., Anil Kumar, N. V., Zucca, P., Varoni, E. M., Dini, L., Panzarini, E., Rajkovic, J., Tsouh Fokou, P. V., Azzini, E., Peluso, I., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00694 · Cited by 1,971
van Es, M. A., Hardiman, O., Chio, A., Al-Chalabi, A., Pasterkamp, R. J., Veldink, J. H., & van den Berg, L. H. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31287-4 · Cited by 1,298
Self-citationAutophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities
Menzies, F. M., Fleming, A., Caricasole, A., Bento, C. F., Andrews, S. P., Ashkenazi, A., Füllgrabe, J., Jackson, A., Jimenez Sanchez, M., Karabiyik, C., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.01.022 · Cited by 1,134
Chemical Basis of Reactive Oxygen Species Reactivity and Involvement in Neurodegenerative Diseases
Collin, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102407 · Cited by 816
Oxidative Stress in Neurodegenerative Diseases
Niedzielska, E., Smaga, I., Gawlik, M., Moniczewski, A., Stankowicz, P., Pera, J., & Filip, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9337-5 · Cited by 800
Metadata
- Authors
- Blokhuis, A. M., Groen, E. J. N., Koppers, M., van den Berg, L. H., & Pasterkamp, R. J.
- Venue
- Acta Neuropathologica
- Published
- 2013-05-15
- Volume
- 125
- Issue
- 6
- Pages
- 777-794
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2120469195
- Cited by
- 579
- References
- 224
- FWCI
- 19.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.